In this context, endogenous tryptophan metabolites are increasingly recognized for their regulatory roles
Designed for precision research, DSIP is primarily investigated for its unique ability to cross the blood-brain barrier and modulate rhythmic biological processes without the heavy sedative effects associated with traditional pharmacological agents
BPC-157 (Body Protection Compound-157) is an artificial peptide composed of 15 amino acids, based on a natural protein that is present in the stomach, and that is studied due to its healing and regenerative effects
J Physiol Paris 93:479485 Sikiric P, Seiwerth S, Brcic L, Blagaic AB, Zoricic I, Sever M, Klicek R, Radic B, Keller N, Sipos K et al (2006) Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease (PL-10, PLD-116, PL 14736, Pliva, Croatia)
[DOI] [PubMed] [Google Scholar] 146.Gjurasin M., Miklic P., Zupancic B., Perovic D., Zarkovic K., Brcic L., Kolenc D., Radic B., Seiwerth S., Sikiric P
The FDA label reports an incidence of approximately 0.1% at doses up to 300 mg/day, rising to 0.4% at 450 mg/day [3]